Works matching IS 03407004 AND DT 2025 AND VI 74 AND IP 4

Results: 34

Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03992-7

By:

Nguyen, Cao Minh;
Vu, Trung T.;
Nguyen, Minh Nguyen;
Tran-Nguyen, Thao-Suong;
Huynh, Chi Thien;
Ha, Quang Thanh;
Nguyen, Hoai-Nghia;
Tran, Le Son

Publication type:

Article

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03959-8

By:

Kim, Chaeyeon;
Han, Mina;
Kim, Gamin;
Son, Wonrak;
Kim, Jeongah;
Gil, Minchan;
Rhee, Yong-Hee;
Sim, Nam Suk;
Kim, Chang Gon;
Kim, Hye Ryun

Publication type:

Article

Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03997-2

By:

Vo, Manh-Cuong;
Nguyen, Van-Tan;
Tran, Van-Dinh-Huan;
Oh, Hyung-Joo;
Jung, Sung-Hoon;
Bae, Woo Kyun;
Lee, Je-Jung;
Oh, In-Jae

Publication type:

Article

Microbial dysbiosis with tryptophan metabolites alteration in lower respiratory tract is associated with clinical responses to anti-PD-1 immunotherapy in advanced non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03996-3

By:

Chen, Xiang-xiang;
Ju, Qing;
Qiu, Dan;
Zhou, Ying;
Wang, Yuan;
Zhang, Xin-xin;
Li, Jing-geng;
Wang, Min;
Chang, Ning;
Xu, Xiang-rui;
Zhang, Yi-bo;
Zhao, Tong;
Wang, Ke;
Zhang, Yong;
Zhang, Jian

Publication type:

Article

Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03994-5

By:

Zhao, Yuze;
Song, Yuguang;
Li, Weiping;
Wu, Jiangping;
Zhao, Zhengbao;
Qu, Tingli;
Xiao, Hong;
Wang, Manyuan;
Zhu, Min;
Zheng, Peiming;
Wan, Huili;
Song, Qingkun;
Zheng, Huixia;
Wang, Shuo

Publication type:

Article

Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03993-6

By:

Wang, Xuefeng;
Li, Tingyi;
Slebos, Robbert J. C.;
Chaudhary, Ritu;
Guevara-Patino, Jose A.;
Bonomi, Marcelo;
Saba, Nabil F.;
Chung, Christine H.

Publication type:

Article

PRMT5 highly expressed on CD16 + CD56- natural killer cells is correlated with NK cells exhaustion in colorectal cancer mesenchyme.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03981-w

By:

Nie, Zunzhen;
Chang, Juanjuan;
Yang, Zhiqin;
Zeng, Kaixuan;
Liu, Yuangang;
Tu, Qian;
Wang, Chao;
Yan, Qingguo;
Shi, Hai;
Guo, Ying

Publication type:

Article

ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03978-5

By:

Wirbel, Chloé;
Durand, Simon;
Boivin, Félix;
Plaschka, Maud;
Benboubker, Valentin;
Grimont, Maxime;
Barbollat-Boutrand, Laetitia;
Tondeur, Garance;
Balme, Brigitte;
Harou, Olivier;
Eberhardt, Anaïs;
Dalle, Stéphane;
Lopez, Jonathan;
Caramel, Julie

Publication type:

Article

Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03970-z

By:

Lu, Zhihao;
Sun, Guoping;
Li, Jiancheng;
Zhao, Jun;
Wang, Zishu;
Qian, Dong;
Yang, Zhe;
Li, Na;
Wang, Junsheng;
Yuan, Shuanghu;
Wang, Yusheng;
Li, Suyi;
Yang, Zhen;
Ran, Fengming;
Ji, Yinghua;
Zhu, Shaojin;
Zhang, Yanqiao;
Wang, Chen;
Wan, Lixin;
Zheng, Rongrong

Publication type:

Article

Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03979-4

By:

Kuroda, Hideki;
Kijima, Noriyuki;
Tachi, Tetsuro;
Ikeda, Shunya;
Murakami, Koki;
Nakagawa, Tomoyoshi;
Yaga, Moto;
Nakagawa, Kanji;
Utsugi, Reina;
Hirayama, Ryuichi;
Okita, Yoshiko;
Kagawa, Naoki;
Hosen, Naoki;
Kishima, Haruhiko

Publication type:

Article

LPIN3 promotes colorectal cancer growth by dampening intratumoral CD8+ T cell effector function.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03989-2

By:

Zhang, Xiaoming;
Fang, Hao;
Wu, Wenliang;
Jiang, Congqing;
Wang, Haizhou;
Shi, Yifei

Publication type:

Article

Exploring the role of TIGIT in patients with Small Cell Lung Cancer as a novel predictor of prognosis and immunotherapy response.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03985-6

By:

Liu, Li;
Wu, Peng;
Wang, Bingzhi;
Dong, Jiyan;
Zhang, Chaoqi;
Liu, Wenchao;
Ying, Jianming

Publication type:

Article

Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03976-7

By:

Kato, Hirotaka;
Tsukahara, Tomohide;
Murata, Kenji;
Nishikata, Hiromu;
Mizue, Yuka;
Sasaya, Takashi;
Kubo, Terufumi;
Kanaseki, Takayuki;
Hirohashi, Yoshihiko;
Oyagi, Atsushi;
Maeda, Tatsuo;
Miyazaki, Akihiro;
Torigoe, Toshihiko

Publication type:

Article

NSUN2/ALYREF axis-driven m5C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03986-5

By:

Yang, Yiran;
Cao, Leiqun;
Xu, Xin;
Li, Dan;
Deng, Yiran;
Li, Lan;
Zeng, Bingjie;
Jiang, Haixia;
Shan, Liang;
Huang, Yiwen;
Xu, Yunhua;
Ma, Lifang

Publication type:

Article

NSUN2/ALYREF axis-driven m5C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03986-5

By:

Yang, Yiran;
Cao, Leiqun;
Xu, Xin;
Li, Dan;
Deng, Yiran;
Li, Lan;
Zeng, Bingjie;
Jiang, Haixia;
Shan, Liang;
Huang, Yiwen;
Xu, Yunhua;
Ma, Lifang

Publication type:

Article

Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03972-x

By:

Yijia, Zheng;
Li, Xiaoyu;
Ma, Lina;
Wang, Siying;
Du, Hong;
Wu, Yun;
Yu, Jing;
Xiang, Yunxia;
Xiong, Daiqin;
Shan, Huiting;
Wang, Yubo;
Wang, Zhi;
Hao, Jianping;
Wang, Jie

Publication type:

Article

Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03972-x

By:

Yijia, Zheng;
Li, Xiaoyu;
Ma, Lina;
Wang, Siying;
Du, Hong;
Wu, Yun;
Yu, Jing;
Xiang, Yunxia;
Xiong, Daiqin;
Shan, Huiting;
Wang, Yubo;
Wang, Zhi;
Hao, Jianping;
Wang, Jie

Publication type:

Article

Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacy.

Published in:

2025

By:

Landre, Thierry;
Des Guetz, Gaëtan

Publication type:

Literature Review

A tumor-binding antibody with cross-reactivity to viral antigens.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03975-8

By:

Campa, Michael J.;
Gottlin, Elizabeth B.;
Wiehe, Kevin;
Patz Jr., Edward F.

Publication type:

Article

Revealing the role of regulatory b cells in cancer: development, function and treatment significance.

Published in:

2025

By:

Ye, Ruyu;
Li, Sijia;
Li, Yuxiao;
Shi, Kaixin;
Li, Li

Publication type:

Literature Review

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03971-y

By:

Zhao, Chenchen;
Jia, Bei;
Jiang, Yixing;
Shike, Hiroko;
Annageldiyev, Charyguly;
Cioccio, Joseph;
Minagawa, Kentaro;
Mineishi, Shin;
Ehmann, WChristopher;
Schell, Todd D.;
Cheng, Hua;
Zheng, Hong

Publication type:

Article

Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03969-6

By:

Inderberg, Else Marit;
Singh, Nand;
Miller, Robert;
Arbe-Barnes, Sarah;
Eriksen, Henrik K.;
lversen, Berit;
Juul, Hedvig Vidarsdotter;
Eriksen, Jon Amund;
Handeland, Karianne Risberg

Publication type:

Article

Spatial transcriptomics reveals prognostically LYZ+ fibroblasts and colocalization with FN1+ macrophages in diffuse large B-cell lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03968-7

By:

Dai, Liyuan;
Lou, Ning;
Huang, Liling;
Li, Lin;
Tang, Le;
Shi, Yuankai;
Han, Xiaohong

Publication type:

Article

Machine learning-derived prognostic signature integrating programmed cell death and mitochondrial function in renal clear cell carcinoma: identification of PIF1 as a novel target.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03967-8

By:

Cheng, Guangyang;
Zhou, Zhaokai;
Li, Shiqi;
Peng, Fu;
Yang, Shuai;
Ren, Chuanchuan

Publication type:

Article

Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03966-9

By:

Ramos-Guerra, Ana D.;
Farina, Benito;
Rubio Pérez, Jaime;
Vilalta-Lacarra, Anna;
Zugazagoitia, Jon;
Peces-Barba, Germán;
Seijo, Luis M.;
Paz-Ares, Luis;
Gil-Bazo, Ignacio;
Dómine Gómez, Manuel;
Ledesma-Carbayo, María J.

Publication type:

Article

From silent partners to potential therapeutic targets: macrophages in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03965-w

By:

Khizar, Hayat;
Ali, Kamran;
Wang, Jianwei

Publication type:

Article

CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03964-x

By:

Sirniö, Päivi;
Elomaa, Hanna;
Tuomisto, Anne;
Äijälä, Ville K.;
Karjalainen, Henna;
Kastinen, Meeri;
Tapiainen, Vilja V.;
Sirkiä, Onni;
Ahtiainen, Maarit;
Helminen, Olli;
Wirta, Erkki-Ville;
Rintala, Jukka;
Meriläinen, Sanna;
Saarnio, Juha;
Rautio, Tero;
Seppälä, Toni T.;
Böhm, Jan;
Mecklin, Jukka-Pekka;
Mäkinen, Markus J.;
Väyrynen, Juha P.

Publication type:

Article

An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03963-y

By:

Dong, Liyuan;
Ma, Yue;
Cao, Guang;
Chen, Dongze;
Dong, Fengxiao;
Jiao, Xi;
Cao, Yanshuo;
Liu, Chang;
Wang, Yanni;
Zhuo, Na;
Wang, Fengyuan;
Guo, Yixuan;
Dai, Tingting;
Zhang, Shuwei;
Jiao, Hao;
Zou, Xingyue;
Li, Jian;
Shen, Lin;
He, Zhonghu;
Zhang, Yanqiao

Publication type:

Article

Comparison of neoadjuvant chemoimmunotherapy with planned surgery and concurrent chemoradiation followed by immunotherapy for potentially resectable stage III non-small-cell lung cancer: a retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03961-0

By:

Qi, Yana;
Zhai, Xiaoyang;
Xu, Qinhao;
Jin, Yuqin;
Guo, Yingfan;
Zhao, Miaoqing;
Zhu, Hui;
Guo, Hongbo

Publication type:

Article

Harnessing TAGAP to improve immunotherapy for lung squamous carcinoma treatment by targeting c-Rel in CD4+ T cells.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03960-1

By:

Cai, Peian;
Sun, Haibo;
Jiang, Tongmeng;
Li, Huawei;
Huang, Dejing;
Hao, Xiaopei;
Wang, Wei;
Xing, Wenqun;
Liang, Guanghui

Publication type:

Article

Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03958-9

By:

Cheng, Jing;
Kang, Wenwen;
Chen, Yueying;
Pan, Luyun;
Han, Hedong;
Lv, Tangfeng

Publication type:

Article

Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03957-w

By:

Yin, Gaofei;
Li, Nuan;
Chen, Xiaohong;
Zhang, Yang;
Huang, Zhigang;
Guo, Wei

Publication type:

Article

Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-024-03918-9

By:

Szóstak, Natalia;
Budnik, Michał;
Tomela, Katarzyna;
Handschuh, Luiza;
Samelak-Czajka, Anna;
Pietrzak, Bernadeta;
Schmidt, Marcin;
Kaczmarek, Mariusz;
Galus, Łukasz;
Mackiewicz, Jacek;
Mackiewicz, Andrzej;
Kozlowski, Piotr;
Philips, Anna

Publication type:

Article

Comprehensive analysis and experimental validation of disulfidptosis-associated prognostic signature and immune microenvironment characterization of gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-024-03883-3

By:

Zhang, Huangjie;
Hu, Jinguo;
Li, Yuanqiang;
Liu, Yanyang;
Shen, Huize;
Wang, Zeng;
Li, Qinglin

Publication type:

Article

Works matching IS 03407004 AND DT 2025 AND VI 74 AND IP 4

Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model.

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.

Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer.

Microbial dysbiosis with tryptophan metabolites alteration in lower respiratory tract is associated with clinical responses to anti-PD-1 immunotherapy in advanced non-small cell lung cancer.

Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment.

Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab.

PRMT5 highly expressed on CD16 + CD56- natural killer cells is correlated with NK cells exhaustion in colorectal cancer mesenchyme.

ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma.

Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies.

Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma.

LPIN3 promotes colorectal cancer growth by dampening intratumoral CD8<sup>+</sup> T cell effector function.

Exploring the role of TIGIT in patients with Small Cell Lung Cancer as a novel predictor of prognosis and immunotherapy response.

Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1.

NSUN2/ALYREF axis-driven m<sup>5</sup>C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer.

NSUN2/ALYREF axis-driven m<sup>5</sup>C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer.

Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma.

Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma.

Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacy.

A tumor-binding antibody with cross-reactivity to viral antigens.

Revealing the role of regulatory b cells in cancer: development, function and treatment significance.

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.

Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study.

Spatial transcriptomics reveals prognostically LYZ<sup>+</sup> fibroblasts and colocalization with FN1<sup>+</sup> macrophages in diffuse large B-cell lymphoma.

Machine learning-derived prognostic signature integrating programmed cell death and mitochondrial function in renal clear cell carcinoma: identification of PIF1 as a novel target.

Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data.

From silent partners to potential therapeutic targets: macrophages in colorectal cancer.

CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancer.

An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinoma.

Comparison of neoadjuvant chemoimmunotherapy with planned surgery and concurrent chemoradiation followed by immunotherapy for potentially resectable stage III non-small-cell lung cancer: a retrospective study.

Harnessing TAGAP to improve immunotherapy for lung squamous carcinoma treatment by targeting c-Rel in CD4+ T cells.

Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer.

Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer.

Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy.

Comprehensive analysis and experimental validation of disulfidptosis-associated prognostic signature and immune microenvironment characterization of gastric cancer.